Trinity Biotech agrees in principle to take minority stake in Latch Medical
TRIB•Support from Perceptive Advisors
Perceptive Advisors, Trinity Biotech’s largest financial investor, will support the planned equity investment.
Development focus for CGM+ and Pharma Latch
The investment aims to support development of biosensor-guided precision drug delivery using Trinity Biotech’s CGM+ platform with Latch Medical’s Pharma Latch technology.
Strategic equity investment and collaboration
Trinity Biotech agreed in principle to make a strategic equity investment in Latch Medical as part of a new collaboration.
The deal positions Trinity Biotech as a minority shareholder in Latch Medical alongside the partnership.
